Koshinski Asset Management Portfolio holdings
AUM
$1.32B
This Quarter Return
+6.01%
1 Year Return
+15.49%
3 Year Return
+57.36%
5 Year Return
+98.18%
10 Year Return
+202.18%
AUM
$795M
AUM Growth
+$795M
(-16%)
Cap. Flow
-$197M
Cap. Flow
% of AUM
-24.74%
Top 10 Holdings %
Top 10 Hldgs %
19.79%
Holding
648
New
60
Increased
62
Reduced
419
Closed
101
Top Buys
Top Sells
| 1 |
Apple
AAPL
|
$10.5M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$6.79M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
$4.27M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
$4.17M |
| 5 |
SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
$3.55M |
Sector Composition
| 1 | Technology | 10.68% |
| 2 | Industrials | 6.07% |
| 3 | Consumer Discretionary | 5.33% |
| 4 | Healthcare | 5.15% |
| 5 | Consumer Staples | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
DigitalBridge
DBRG
$2.08B
| $258K | 0.03% |
32,700
-2,000
| -6% | -$15.8K |
|
477
Vanguard Mid-Cap Value ETF
VOE
$18.8B
| $258K | 0.03% |
1,837
-434
| -19% | -$61K |
|
478
Innovator US Equity Buffer ETF March
BMAR
$224M
| $257K | 0.03% |
7,841
| – | – |
|
479
International Paper
IP
$26.2B
| $257K | 0.03% |
4,193
-1,162
| -22% | -$71.2K |
|
480
Novartis
NVS
$245B
| $257K | 0.03% |
2,812
-1,006
| -26% | -$91.9K |
|
481
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$675M
| $256K | 0.03% |
10,000
-5,500
| -35% | -$141K |
|
482
Innovator Growth-100 Power Buffer ETF January
NJAN
$296M
| $256K | 0.03% |
6,290
-1,195
| -16% | -$48.6K |
|
483
Designer Brands
DBI
$181M
| $255K | 0.03% |
15,414
-40,693
| -73% | -$673K |
|
|
ADRE
484
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
| $255K | 0.03% |
4,395
-962
| -18% | -$55.8K |
|
485
WisdomTree US MidCap Dividend Fund
DON
$3.83B
| $250K | 0.03% |
5,963
-2,755
| -32% | -$116K |
|
486
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.15B
| $250K | 0.03% |
3,804
-3,313
| -47% | -$218K |
|
487
Pure Cycle
PCYO
$243M
| $246K | 0.03% |
17,800
-1,500
| -8% | -$20.7K |
|
488
CME Group
CME
$96B
| $245K | 0.03% |
1,154
+55
| +5% | +$11.7K |
|
489
iShares MSCI India ETF
INDA
$9.17B
| $245K | 0.03% |
5,532
-11,060
| -67% | -$490K |
|
490
Boston Scientific
BSX
$156B
| $242K | 0.03% |
5,652
+50
| +0.9% | +$2.14K |
|
491
DocuSign
DOCU
$15.5B
| $242K | 0.03% |
+865
| New | +$242K |
|
492
1-800-Flowers.com
FLWS
$356M
| $242K | 0.03% |
7,600
-3,289
| -30% | -$105K |
|
493
First Trust Preferred Securities and Income ETF
FPE
$6.1B
| $242K | 0.03% |
11,736
-14,074
| -55% | -$290K |
|
494
GoodRx Holdings
GDRX
$1.51B
| $239K | 0.03% |
6,631
-21,093
| -76% | -$760K |
|
495
Novo Nordisk
NVO
$251B
| $237K | 0.03% |
2,835
-536
| -16% | -$44.8K |
|
496
GSK
GSK
$79.9B
| $236K | 0.03% |
5,915
-2,424
| -29% | -$96.7K |
|
497
Southwest Airlines
LUV
$17.3B
| $236K | 0.03% |
4,437
-2,577
| -37% | -$137K |
|
498
Carnival Corp
CCL
$43.2B
| $235K | 0.03% |
+8,925
| New | +$235K |
|
|
VSTO
499
DELISTED
Vista Outdoor Inc.
VSTO
| $235K | 0.03% |
+5,069
| New | +$235K |
|
500
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| $234K | 0.03% |
4,261
-1,095
| -20% | -$60.1K |
|